RAS screening in colorectal cancer: A comprehensive analysis of the results from the UK NEQAS Colorectal Cancer External Quality Assurance schemes (2009-2016).

Susan D. Richman, Jennifer Fairley, Rachel Butler, Zandra C. Deans. Virchows Arch 2017 Dec;471(6):721-729. doi: 10.1007/s00428-017-2162-7.

Recommended practice for laboratory reporting of non-invasive prenatal testing of trisomies 13, 18 and 21: a consensus opinion.

Deans ZC, Allen S, Jenkins L, Khawaja F, Hastings RJ, Mann K, Patton SJ, Sistermans EA, Chitty LS. Prenat Diagn. 2017 Jul;37(7):699-704. doi: 10.1002/pd.5068. Epub 2017 Jun 8.

The ins and outs of molecular pathology reporting.

Tack V, Dufraing K, Deans ZC, van Krieken HJ, Dequeker EM. Virchows Arch. 2017 Mar 26.

How close are we to standardised extended RAS gene mutation testing? The UK NEQAS evaluation.

Richman SD et al. J Clin Pathol. 2017 Jan;70(1):58-62.

Fading competency of cytogenetic diagnostic laboratories: the alarm bell has started to ring

Hochstenbach R, Slunga-Tallberg A, Devlin C, Floridia G, de Alba MR, Bhola S, Rack K, Hastings R. Eur J Hum Genet. 2017 Feb;25(3):273-274.